Literature DB >> 17940971

Cytokine and chemokine expression in humans infected with Sudan Ebola virus.

Karen L Hutchinson1, Pierre E Rollin.   

Abstract

The size and duration of the 2000 outbreak of Sudan Ebola virus (SEBOV) infection in Uganda made it possible to collect serial serum samples from 87 patients (53 survivors and 34 nonsurvivors). Surprisingly, the levels of tumor necrosis factor- alpha and interferon (IFN)- gamma , which had been found to be increased in patients with fatal Zaire Ebola virus infection, were not increased in any of the patients with SEBOV infection. The levels of interleukin (IL)-1 beta , IFN- gamma -inducible protein-10, and RANTES (regulated on activation, normally T cell-expressed and -secreted) were higher in samples from all patients with SEBOV infection than in control samples from healthy hospital staff members, but their levels did not differ between those who survived and those who did not. The levels of IFN- alpha were significantly higher in surviving patients with SEBOV infection, whereas the levels of IL-6, IL-8, IL-10, and macrophage inflammatory protein-1 beta were higher in patients with fatal SEBOV infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940971     DOI: 10.1086/520611

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  64 in total

1.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Robust and sustained immune activation in human Ebola virus infection.

Authors:  Judith N Mandl; Mark B Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-07       Impact factor: 11.205

3.  Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Authors:  John C Kash; Kathie-Anne Walters; Jason Kindrachuk; David Baxter; Kelsey Scherler; Krisztina B Janosko; Rick D Adams; Andrew S Herbert; Rebekah M James; Spencer W Stonier; Matthew J Memoli; John M Dye; Richard T Davey; Daniel S Chertow; Jeffery K Taubenberger
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

4.  Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.

Authors:  Jessica R Spengler; Kerry J Lavender; Cynthia Martellaro; Aaron Carmody; Andreas Kurth; James G Keck; Greg Saturday; Dana P Scott; Stuart T Nichol; Kim J Hasenkrug; Christina F Spiropoulou; Heinz Feldmann; Joseph Prescott
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

5.  Biomarkers for understanding Ebola virus disease.

Authors:  Anita K McElroy; Christina F Spiropoulou
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

6.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

7.  A Syrian golden hamster model recapitulating ebola hemorrhagic fever.

Authors:  Hideki Ebihara; Marko Zivcec; Donald Gardner; Darryl Falzarano; Rachel LaCasse; Rebecca Rosenke; Dan Long; Elaine Haddock; Elizabeth Fischer; Yoshihiro Kawaoka; Heinz Feldmann
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

Review 8.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

9.  Ebola: Implications and Perspectives.

Authors:  Carlos Del Rio; Jeannette Guarner
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

10.  The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever.

Authors:  Emine Parlak; Ayşe Ertürk; Yasemin Çağ; Engin Sebin; Musa Gümüşdere
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.